Evidence map›Paper›PMID 41636549›Full record

ArticleStatistics in medicine2026

Assessing Treatment Effects in Observational Data With Missing Confounders: A Comparative Study of Practical Doubly-Robust and Traditional Missing Data Methods.

Brian D Williamson, Chloe Krakauer, Eric Johnson, Susan Gruber, Bryan E Shepherd, Mark J van der Laan, Thomas Lumley, Hana Lee, José J Hernández-Muñoz, Fengyu Zhao and 6 more

Abstract readComparative Study
In one paragraph

Article in Statistics in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Brian D WilliamsonBiostatistics Division, Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.ORCID https://orcid.org/0000-0002-7024-548X
Chloe KrakauerBiostatistics Division, Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
Eric JohnsonBiostatistics Division, Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
Susan GruberTL Revolution, LLC, Cambridge, Massachusetts, USA.
Bryan E ShepherdDepartment of Biostatistics, Vanderbilt University, Nashville, Tennessee, USA.
Mark J van der LaanDepartment of Biostatistics, School of Public Health, University of California at Berkeley, Berkeley, California, USA.
Thomas LumleyDepartment of Statistics, University of Auckland, Auckland, New Zealand.
Hana LeeOffice of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.ORCID https://orcid.org/0000-0001-9497-0574
José J Hernández-MuñozOffice of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Fengyu ZhaoOffice of Biostatistics, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Sarah K DutcherOffice of Surveillance and Epidemiology, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA.
Rishi DesaiDivision of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Gregory E SimonInvestigative Science Division, Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
Susan M ShortreedBiostatistics Division, Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
Jennifer C NelsonBiostatistics Division, Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.
Pamela A ShawBiostatistics Division, Kaiser Permanente Washington Health Research Institute, Seattle, Washington, USA.ORCID https://orcid.org/0000-0003-1883-8410

Funding

Statistical methods and designs for correlated outcome and covariate errors in studies of HIV/AIDSR37AI131771 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Pamela A Shaw, Bryan Earl Shepherd · 2023 to 2026
$3.4M
NIAID NIH HHS R37 AI131771NIH HHS R37AI131771U.S. Food and Drug Administration 75F40123F19006
6 · The paper itself

Abstract

In pharmacoepidemiology, safety and effectiveness are frequently evaluated using readily available administrative and electronic health records data. In these settings, detailed confounder data are often not available in all data sources and therefore missing on a subset of individuals. Multiple imputation (MI) and inverse-probability weighting (IPW) are go-to analytical methods to handle missing data and are dominant in the biomedical literature. Doubly-robust methods, which are consistent under fewer assumptions, can be more efficient with respect to mean-squared error. We discuss two practical-to-implement doubly-robust estimators, generalized raking and inverse probability-weighted targeted maximum likelihood estimation (TMLE), which are both currently under-utilized in biomedical studies. We compare their performance to IPW and MI in a detailed numerical study for a variety of synthetic data-generating and missingness scenarios, including scenarios with rare outcomes and a high missingness proportion. Further, we consider plasmode simulation studies that emulate the complex data structure of a large electronic health records cohort in order to compare anti-depressant therapies in a rare-outcome setting where a key confounder is prone to more than 50% missingness. We provide guidance on selecting a missing data analysis approach, based on which methods excelled with respect to the bias-variance trade-off across the different scenarios studied.

Indexed as

Observational Studies as TopicAntidepressive AgentsBiasComputer SimulationConfounding Factors, EpidemiologicData Interpretation, StatisticalElectronic Health RecordsHumansLikelihood FunctionsModels, StatisticalPharmacoepidemiologyTreatment OutcomeAntidepressive Agents

Identifiers

PMID41636549
PMCPMC12875654

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.